PEX1G843D remains functional in peroxisome biogenesis but is rapidly degraded by the proteasome
Journal of Biological Chemistry · 2025-05 · 301 (5) · 108467
DOI: 10.1016/j.jbc.2025.108467 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biological Chemistry, 2025-05. Verfasst von Connor J Sheedy und 8 weiteren Autor:innen. Beteiligte Einrichtung: Biomolecular Science and Engineering Program, University of California, Santa Barbara, Santa Barbara, California, USA. Hauptthemen laut MEDLINE: Peroxisomes, Proteasome Endopeptidase Complex, Proteolysis, Membrane Proteins. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
The PEX1/PEX6 AAA-ATPase is required for the biogenesis and maintenance of peroxisomes. Mutations in HsPEX1 and HsPEX6 disrupt peroxisomal matrix protein import and are the leading cause of peroxisome biogenesis disorders. The most common disease-causing mutation in PEX1 is the HsPEX1G843D allele, which results in a reduction of peroxisomal protein import. Here, we demonstrate that the homologous yeast mutant, ScPex1G700D, reduces the stability of Pex1's active D2 ATPase domain and impairs assembly with Pex6 in vitro, but can still form an active AAA-ATPase motor. In vivo, ScPex1G700D exhibits only a slight defect in peroxisome import. We generated model human HsPEX1G843D cell lines and show that PEX1G843D is rapidly degraded by the proteasome, but that induced overexpression of PEX1G843D can restore peroxisome import. Additionally, we found that the G843D mutation reduces PEX1's affinity for PEX6, and that impaired assembly is sufficient to induce degradation of PEX1WT. Lastly, we found that fusing a deubiquitinase to PEX1G843D significantly hinders its degradation in mammalian cells. Altogether, our findings suggest a novel regulatory mechanism for PEX1/PEX6 hexamer assembly and highlight the potential of protein stabilization as a therapeutic strategy for peroxisome biogenesis disorders arising from the G843D mutation and other PEX1 hypomorphs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Biomolecular Science and Engineering Program, University of California, Santa Barbara, Santa Barbara, California, USA.
- Department of Molecular, Cellular, and Developmental Biology, University of California, Santa Barbara, Santa Barbara, California, USA.
- Department of Ecology, Evolution, and Marine Biology, University of California, Santa Barbara, Santa Barbara, California, USA.
- Department of Molecular, Cellular, and Developmental Biology, University of California, Santa Barbara, Santa Barbara, California, USA. Electronic address: brookegardner@ucsb.edu.
Förderung
- NIGMS NIH HHS
- NIH HHS
- National Institutes of Health
- Kinship Foundation
- National Science Foundation Graduate Research Fellowship Program
- NIH National Institute of General Medical Sciences
- Searle Scholars Program
- University of California, Davis
Zitieren
APA
Sheedy, C. J., Chowdhury, S. P., Ali, B. A., Miyamoto, J., Pang, E. Z., Bacal, J., Tavasoli, K. U., Richardson, C. D., & Gardner, B. M. (2025). PEX1G843D remains functional in peroxisome biogenesis but is rapidly degraded by the proteasome. Journal of Biological Chemistry, 301(5), 108467. https://doi.org/10.1016/j.jbc.2025.108467
Vancouver
Sheedy CJ, Chowdhury SP, Ali BA, Miyamoto J, Pang EZ, Bacal J, et al. PEX1G843D remains functional in peroxisome biogenesis but is rapidly degraded by the proteasome. Journal of Biological Chemistry. 2025;301(5):108467. doi:10.1016/j.jbc.2025.108467
BibTeX
@article{Sheedy2025,
author = {Sheedy, Connor J and Chowdhury, Soham P and Ali, Bashir A and Miyamoto, Julia and Pang, Eric Z and Bacal, Julien and Tavasoli, Katherine U and Richardson, Chris D and Gardner, Brooke M},
title = {PEX1G843D remains functional in peroxisome biogenesis but is rapidly degraded by the proteasome},
journal = {Journal of Biological Chemistry},
year = {2025},
volume = {301},
number = {5},
pages = {108467},
doi = {10.1016/j.jbc.2025.108467}
}
EUVIMED